The role of capsule endoscopy in suspected celiac disease patients with positive celiac serology

Lidums, Ilmars; Cummins, Adrian; Teo, Edward; Cummins, Adrian G
February 2011
Digestive Diseases & Sciences;Feb2011, Vol. 56 Issue 2, p499
Academic Journal
journal article
Background: Endomysial antibody (EMA) and tissue transglutaminase (tTG) antibody testing is used to screen subjects with suspected celiac disease. However, the traditional gold standard for the diagnosis of celiac disease is histopathology of the small bowel. As villous atrophy may be patchy, duodenal biopsies could potentially miss the abnormalities. Capsule endoscopy can obtain images of the whole small intestine and may be useful in the early diagnosis of celiac disease.Aims: To evaluate suspected celiac disease patients who have positive celiac serology and normal duodenal histology and to determine, with capsule endoscopy, whether these patients have any endoscopic markers of celiac disease.Methods: Twenty-two subjects with positive celiac serology (EMA or tTG) were prospectively evaluated. Eight of the subjects had normal duodenal histology and 14 had duodenal histology consistent with celiac disease. All subjects underwent capsule endoscopy. Endoscopic markers of villous atrophy such as loss of mucosal folds, scalloping, mosaic pattern, and visible vessels were assessed.Results: Eight subjects with normal duodenal histology had normal capsule endoscopy findings. In the 14 subjects with duodenal histology that was consistent with celiac disease, 13 had celiac disease changes seen at capsule endoscopy. One subject with normal capsule endoscopy findings showed Marsh IIIc on duodenal histology. Using duodenal histology as the gold standard, capsule endoscopy had a sensitivity of 93%, specificity of 100%, PPV of 100%, and NPV of 89% in recognizing villous atrophy.Conclusions: Capsule endoscopy is useful in the detection of villous abnormalities in untreated celiac disease. Patients with positive celiac serology (EMA or tTG) and normal duodenal histology are unlikely to have capsule endoscopy markers of villous atrophy.


Related Articles

  • Serologic testing for celiac disease in young people with elevated transaminases. Juanli YUAN; Jinyan GAO; Yonghong YAO; Hongbing CHEN // Turkish Journal of Medical Sciences;2015, Vol. 45 Issue 3, p668 

    Background/aim: A cryptogenic elevation of transaminases is the most common hepatic manifestation in celiac disease (CD). In adult patients and pediatric patients with cryptogenic hypertransaminasemia, the prevalence of CD was 4% and 12%, respectively. However, there are no related data from...

  • Serological Assessment for Celiac Disease in IgA Deficient Adults. Wang, Ning; Truedsson, Lennart; Elvin, Kerstin; Andersson, Bengt A.; Rönnelid, Johan; Mincheva-Nilsson, Lucia; Lindkvist, Annica; Ludvigsson, Jonas F.; Hammarström, Lennart; Dahle, Charlotte // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Purpose: Selective immunoglobulin A deficiency is the most common primary immunodeficiency disorder that is strongly overrepresented among patients with celiac disease (CD). IgG antibodies against tissue transglutaminase (tTG) and deamidated gliadin peptides (DGP) serve as serological markers...

  • Anti-transglutaminase immunoreactivity and histological lesions of the duodenum in coeliac patients. Nenna, Raffaella; Tiberti, Claudio; Petrarca, Laura; Mennini, Maurizio; Mastrogiorgio, Gerarda; Lucantoni, Federica; Panimolle, Francesca; Pontone, Stefano; Bavastrelli, Maria; Magliocca, Fabio Massimo; Bonamico, Margherita // International Immunology;Jun2013, Vol. 25 Issue 6, p389 

    The titre and epitope specificity of anti-tTG antibodies correlate with duodenal pathology in coeliac diseaseCoeliac disease (CD) is characterized by several markers, including anti-transglutaminase auto-antibodies (tTGAb) directed against multiple epitopes of the gliadin protein. We aimed to...

  • Serological Markers of Enterocyte Damage and Apoptosis in Patients With Celiac Disease, Autoimmune Diabetes Mellitus and Diabetes Mellitus Type 2. HOFFMANOVÁ, I.; SÁNCHEZ, D.; HÁBOVÁ, V.; ANDĚL, M.; TUČKOVÁ, L.; TLASKALOVÁ-HOGENOVÁ, H. // Physiological Research;2015, Vol. 64 Issue 4, p537 

    Impairment of mucosal barrier integrity of small intestine might be causative in immune-mediated gastrointestinal diseases. We tested the markers of epithelial apoptosis - cytokeratin 18 caspase-cleaved fragment (cCK-18), and enterocyte damage - intestinal fatty acid-binding protein (I-FABP) and...

  • Erratum to: RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. Martucciello, Stefania; Lavric, Miha; Toth, Boglarka; Korponay-Szabo, Ilma; Nadalutti, Cristina; Myrsky, Essi; Rauhavirta, Tiina; Esposito, Carla; Sulic, Ana-Marija; Sblattero, Daniele; Marzari, Roberto; Mäki, Markku; Kaukinen, Katri; Lindfors, Katri; Caja, Sergio // Journal of Molecular Medicine;Mar2012, Vol. 90 Issue 3, p343 

    A correction to the article "RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies" that was published in the 2011 issue is presented.

  • Laboratory Evaluation of Three Regimens of Treatment of Chronic Hepatitis B: Tenofovir, Entecavir and Combination of Lamivudine and Adefovir. Jayakumar, Rajeswari; Joshi, Yogendra Kumar; Singh, Sarman // Journal of Laboratory Physicians;Jan-Jun2012, Vol. 4 Issue 1, p10 

    Background: Chronic hepatitis B is a disease of concern due to its life-threatening complications like cirrhosis, and hepatocellular carcinoma (HCC) in 20-40% of patients. There are about 400 million people affected worldwide with HBV, and over 300,000 die every year from HBV-related diseases....

  • Coeliac Patients Are Undiagnosed at Routine Upper Endoscopy. Robson, Kathryn; Alizart, Michelle; Martin, Jarad; Nagel, Robyn // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Background and Aims: Two out of three patients with Coeliac Disease (CD) in Australia are undiagnosed. This prospective clinical audit aimed to determine how many CD patients would be undiagnosed if duodenal biopsy had only been performed if the mucosa looked abnormal or the patient presented...

  • Are Treated Celiac Patients at Risk for Mycotoxins? An Italian Case-Study. Cirlini, Martina; Mazzeo, Teresa; Roncoroni, Leda; Lombardo, Vincenza; Elli, Luca; Bardella, Maria T.; Agostoni, Carlo; Doneda, Luisa; Brighenti, Furio; Dall'Asta, Chiara; Pellegrini, Nicoletta // Toxins;Jan2017, Vol. 9 Issue 1, p1 

    Urinary biomarkers of mycotoxin exposure were evaluated in a group of celiac patients (n = 55) and in a control group of healthy subjects (n = 50) following their habitual diet. Deoxynivalenol (DON), zearalenone (ZEN), and fumonisin B1 (FB1) were monitored in 105 urinary samples collected from...

  • Longitudinal Assessment of Histology Surrogate Markers (FibroTest–ActiTest) During Lamivudine Therapy in Patients with Chronic Hepatitis B Infection. Poynard, Thierry; Zoulim, Fabien; Ratziu, Vlad; Degos, Françoise; Imbert-Bismut, Francoise; Deny, Paul; Landais, Paul; El Hasnaoui, Abdelkader; Slama, Alain; Blin, Patrick; Thibault, Vincent; Parvaz, Parviz; Munteanu, Mona; Trepo, Christian // American Journal of Gastroenterology;Sep2005, Vol. 100 Issue 9, p1970 

    OBJECTIVES: The noninvasive serum markers, FibroTest–ActiTest (FT–AT), are an alternative to liver biopsy in patients with chronic hepatitis C and B. The aim was to use these markers in a prospective study of patients treated with lamivudine in order to assess the impact of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics